PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportsthrombocytosis
MeSH D013922 - thrombocytosis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D001791:Blood platelet disorders
0 Companies
0 Drugs
Success rate
D009196:Myeloproliferative disorders
3 Companies
3 Drugs
$
Success rate
D013922: 
Thrombocytosis
13 Companies
3 Drugs
$
Success rate
D013920:Essential thrombocythemia
13 Companies
8 Drugs
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
AllerganAnagrelide Anagrelide  2005-04-18   
Barr PharmaceuticalsAnagrelide Anagrelide  2005-04-18   
Chartwell PharmaceuticalsAnagrelide Anagrelide  2005-04-18   
CiplaAnagrelide Anagrelide  2005-04-18   
Impax LaboratoriesAnagrelide Anagrelide  2005-04-18   
MylanAnagrelide Anagrelide Mylan  2018-02-15   
Novitium PharmaAnagrelide Anagrelide  2005-04-18   
Rising PharmaceuticalsAnagrelide Anagrelide  2006-06-27   
Roxane LaboratoriesAnagrelide Anagrelide  2005-04-18   
1
2
>
Clinical Trials
Historical Success Rate
Phase 1
10%
6/58
Phase 2
0%
0/15
Phase 3
100%
3/3
Approved: 3Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Mylan
Anagrelide,
Anagrelide hydrochloride
Shire
Spd422
Takeda
Anagrelide,
Anagrelide hydrochloride
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use